Eli Lilly Gets CDSCO Panel Nod To Import, Market Anti-cancer Drug Selpercatinib
New Delhi: Advising to conduct the Phase IV clinical trial, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to the pharmaceutical major Eli Lilly to import and market the anti-cancer drug Selpercatinib 40 mg and 80 mg. The expert panel recommended the grant of permission to […]